The company is underwriting an Arthritis Foundation educational campaign to make the public aware of measures available to prevent and treat NSAID-induced ulcers. In a March 30 satellite teleconference to launch the campaign, the foundation presented a panel of experts to discuss NSAID-induced ulcers, as well as a survey of 1,000 doctors' observations on the incidence of NSAID-induced ulcers. Searle has agreed to give over $ 1 mil. in support of the program for the first year. The program is expected to be multi-million dollar project to continue over the course of several years.
You may also be interested in...
Data presented at AAAI meeting show reduced annualized asthma exacerbation rates across all patient populations, but doctors are unlikely to switch patients served well by existing biologics.
The RNA drug’s accelerated approval brings Sarepta’s exon-skipping market share to nearly 30%.
Limiting interactions to two-dimensional settings will hinder collaboration, innovation and the mentoring of younger employees, Merck & Co. CEO Kenneth Frazier says. Frazier, who will retire in June, is looking forward to returning to public service but says "politics with a capital P is not my thing."